Mastering Data Migration – the Blood That Flows through IT Systems
We draw a parallel between two seemingly disparate yet intricately linked processes: a blood transfusion and a data migration.
Supply chain management (SCM) is often underestimated, especially in large diversified chemical companies. However, it offers untapped opportunities for European chemical companies to stand out from the competition and achieve measurable improvements.
There are three reasons to evaluate supply chain management:
In combination, these factors will enhance the position of supply chain management in the company, both qualitatively and organizationally, enabling it to make stronger contributions to satisfying customer requirements and thus increasing the company’s value. Supply chains will continue to be segmented according to individual businesses, but the supply chain function will become more embedded on the corporate level.
To this end, this blog article takes a look at the extent to which the strategic conditions for SCM in the chemical industry changed. These parameters are important to answer questions like the advantages of digital supply chain management and how a realignment of the supply chain (Link part 3) in chemical companies can be designed. The operating models of supply chains in the chemical industry play a key role here.
Customers in the chemical industry, such as those from the automotive accessories, packaging, or food sectors, often have a lower level of added value, sometimes achieve lower margins, and therefore depend on a well-coordinated supply chain. Many of these industries are also ahead of the chemical industry concerning supply chain digitization. It is therefore not surprising that they demand the same standards from their suppliers as they do from their own company.
In contrast, the chemical industry has so far neglected supply chain management as a distinguishing competitive feature. This is true regardless of the many individuals, very intelligent solutions that often transcend the supply chain and link production planning, product and customer portfolio management, or margin optimization across entire value chains. There is no lack of creativity or attention to detail, but there is a lack when it comes to systematic operation of all levers at the entire company level using the latest technologies, and company-wide transparency of efforts and exchange of experience on potentials in the supply chain are insufficient.
There are several reasons why supply chain management has not yet been systematically used as a value lever at the entire company or group level. Most large chemical companies have been organizing themselves into strategic business units (SBUs) for more than twenty years, initially for strategic reasons. This was also accompanied by a differentiation and fragmentation of supply chains and supply chain management, which in some cases is no longer even present at the group level.
Camelot assumes that most large, diversified chemical companies will continue to opt for the strategic business unit model and the decentralized structure of SCM will continue to be the case for the foreseeable future. A more functional organization, like that which exists in medium and smaller chemical companies, could only prevail where (often smaller) businesses with focused product portfolios emerge from their companies via portfolio management and ownership changes.
The trend is rather going in the other direction: individual chemical companies have even been strengthening their decentralized positioning in recent times. As long as portfolio streamlining and growth through acquisition are at the top of CEOs’ agendas, this preference will not change. The differentiation of supply chains also does justice to the diversity of the businesses and has generally proved its worth. There will be ‘no one size fits all’: different supply chains will continue to exist under the umbrella of one chemical company or even one business unit.
The implicit selection of differentiated supply chains has undeniable advantages: the chemical industry as a whole has fared better in competition than predicted around the year 2000, and many individual businesses have developed well-thought-out solutions to business-specific supply chain challenges. But the differentiation of supply chains is also a fragmentation, the disadvantages of which are becoming increasingly apparent: while business units are managed according to operating profit, there is a lack of operational responsibility for supply chain performance, which is why the relevant KPIs (e.g., net working capital) are unsatisfactory in many chemical companies, with corresponding negative consequences for profitable growth. Supply chain know-how and skills are not systematically collected and further developed or are only done so inadequately. This weakens an organization’s ability to recognize and apply innovation quickly.
Lacking this ability is dangerous, especially in the current environment. On the one hand, the cost pressure (from new competitors, high energy prices, etc.), to which the chemical industry in Europe and Germany is exposed, makes it necessary to consistently exploit all potentials for improvement. This forces the use of cost and know-how synergies by pooling resources in the supply chain. On the other hand, many chemical companies are responding to the commoditization of their products or corresponding customer requirements by increasingly differentiating their product/service offerings, e.g. through customer-specific configuration. This in turn drives complexity and cost in the supply chain. Supply chain management in the chemical industry is thus faced with the challenge of supporting differentiation while at the same time streamlining cost structures – seemingly squaring the circle.
This is undoubtedly a delicate trade-off. For it to succeed, it requires a foundation of a digitalized supply chain that is realigned to the changed framework conditions and business specifics.
We draw a parallel between two seemingly disparate yet intricately linked processes: a blood transfusion and a data migration.
This article will illustrate a standard allocation planning model, best practices, and a customized ‘allocation redistribution’ approach.
In our blog article, we assess how well the capabilities of S/4HANA align with various levels of inventory management maturity.
We explore potential challenges and solutions pharmaceutical companies encounter within their digital transformation.
